Clinical Trial Update: The Cooling And Surviving Septic Shock Study (CASS) [Phase 2, Phase 3]

View source ↗

Summary

The Cooling And Surviving Septic Shock Study (CASS) Phase 2/3 trial has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Snippet

Sponsor: Danish Procalcitonin Study Group | Conditions: Septic Shock | Phase 2, Phase 3 | Status: TERMINATED